Bearish
🤖 90%
Gojek Co-Founder Makarim's Trial Exposes Soaring Business Risks in Indonesia
GoTo Group shares drop sharply as founder Nadiem Makarim's trial threatens management stability and corporate reputation. The stock underperforms the broader Jakarta index, falling 8% intraday, as employees and partners fear disruption to ongoing restructuring.
Catalysts
- ▼ Trial directly implicates GoTo's co-founder, raising leadership risks
- ▼ Reputational damage likely to delay profitability targets
Risk Factors
- ▲ Verdict favorable to Makarim removes overhang
- ▲ Business performance remains strong despite legal troubles
▼ Show FAQ (2) ▲ Hide FAQ
What's the direct impact on GoTo shares?
GoTo faces immediate sell pressure as the market prices in elevated uncertainty over leadership and potential regulatory action. The stock could retest its all-time lows if the trial outcome appears negative.
Should investors sell GoTo now?
Risk-averse investors may lighten positions given the heightened binary risk. However, long-term holders might wait for more clarity on the trial’s implications for business operations, as the company's core e-commerce and ride-hailing segments remain robust.